Your browser doesn't support javascript.
loading
The role of endocrine disruptors in female infertility.
Silva, Ana Beatriz P; Carreiró, Filipa; Ramos, Fernando; Sanches-Silva, Ana.
Afiliação
  • Silva ABP; University of Coimbra, Faculty of Pharmacy, Azinhaga de Santa Comba, 3000-548, Coimbra, Portugal.
  • Carreiró F; University of Coimbra, Faculty of Pharmacy, Azinhaga de Santa Comba, 3000-548, Coimbra, Portugal.
  • Ramos F; National Institute of Agrarian and Veterinary Research (INIAV), Rua dos Lagidos, Lugar da Madalena, Vairão, 4485-655, Vila do Conde, Portugal.
  • Sanches-Silva A; University of Coimbra, Faculty of Pharmacy, Azinhaga de Santa Comba, 3000-548, Coimbra, Portugal.
Mol Biol Rep ; 50(8): 7069-7088, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37402067
ABSTRACT

INTRODUCTION:

 According to the World Health Organization, infertility is a public health problem that affects around 48 million couples and 186 million individuals worldwide. Endocrine disruptors are one of the causes that raise more concern, given that it is a problem that has evolved with the progress of society. Many chemicals are used by food industry, entering food chain, and directly affecting human health. Endocrine disruptors have the capacity of interfering with the normal hormonal action, metabolism, and biosynthesis, which can lead to a variation of the normal hormonal homeostasis. Some of these endocrine disruptors are highly associated with diseases that are positively correlated with female infertility, such as polycystic ovary syndrome, endometriosis, irregular menstrual cycle and also disturbances on processes as steroidogenesis and development of the ovarian follicles.

RESULTS:

The present literature review covers various aspects of the possible relationship between endocrine disruptors and female infertility. Bisphenol A and its metabolites, phthalates, dioxins, organochlorine, and organophosphate compounds are groups of chemicals considered to have the capacity to disrupt endocrine activity and herein addressed. The results reported in in vivo studies and in clinical trials addressing endocrine disruptors and female infertility were discussed as well as their possible mechanism of action.

CONCLUSIONS:

Large, double-blind, placebo-controlled randomized clinical trials are needed to better understand the mechanisms of action of endocrine disruptors in female infertility, as well as the doses and frequency of exposure responsible for it.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Endometriose / Poluentes Ambientais / Disruptores Endócrinos / Infertilidade Feminina Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Endometriose / Poluentes Ambientais / Disruptores Endócrinos / Infertilidade Feminina Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article